179 related articles for article (PubMed ID: 25814778)
1. BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.
Laraqui A; Uhrhammer N; Rhaffouli HE; Sekhsokh Y; Lahlou-Amine I; Bajjou T; Hilali F; El Baghdadi J; Al Bouzidi A; Bakri Y; Amzazi S; Bignon YJ
Dis Markers; 2015; 2015():194293. PubMed ID: 25814778
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
ElBiad O; Laraqui A; El Boukhrissi F; Mounjid C; Lamsisi M; Bajjou T; Elannaz H; Lahlou AI; Kouach J; Benchekroune K; Oukabli M; Chahdi H; Ennaji MM; Tanz R; Sbitti Y; Ichou M; Ennibi K; Badaoui B; Sekhsokh Y
BMC Cancer; 2022 Feb; 22(1):208. PubMed ID: 35216584
[TBL] [Abstract][Full Text] [Related]
3. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.
Mahfoudh W; Bouaouina N; Ahmed SB; Gabbouj S; Shan J; Mathew R; Uhrhammer N; Bignon YJ; Troudi W; Elgaaied AB; Hassen E; Chouchane L
Mol Biol Rep; 2012 Feb; 39(2):1037-46. PubMed ID: 21603858
[TBL] [Abstract][Full Text] [Related]
4. Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.
Laraqui A; Uhrhammer N; Lahlou-Amine I; El Rhaffouli H; El Baghdadi J; Dehayni M; Moussaoui RD; Ichou M; Sbitti Y; Al Bouzidi A; Amzazi S; Bignon YJ
Int J Med Sci; 2013; 10(1):60-7. PubMed ID: 23289006
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases.
Uhrhammer N; Abdelouahab A; Lafarge L; Feillel V; Ben Dib A; Bignon YJ
Int J Med Sci; 2008 Jul; 5(4):197-202. PubMed ID: 18645608
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 germline mutation spectrum in hereditary breast/ovarian cancer families from Maghrebian countries.
Cherbal F; Bakour R; Adane S; Boualga K
Breast Dis; 2012; 34(1):1-8. PubMed ID: 23697973
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.
Gabaldó Barrios X; Sarabia Meseguer MD; Marín Vera M; Sánchez Bermúdez AI; Macías Cerrolaza JA; Sánchez Henarejos P; Zafra Poves M; García Hernández MR; Cuevas Tortosa E; Aliaga Baño Á; Castillo Guardiola V; Martínez Hernández P; Tovar Zapata I; Martínez Barba E; Ayala de la Peña F; Alonso Romero JL; Noguera Velasco JA; Ruiz Espejo F
Fam Cancer; 2017 Oct; 16(4):477-489. PubMed ID: 28477318
[TBL] [Abstract][Full Text] [Related]
8. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
[TBL] [Abstract][Full Text] [Related]
9. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso.
Zoure AA; Slaoui M; Bambara HA; Sawadogo AY; Compaoré TR; Ouédraogo NLM; Mzibri ME; Attaleb M; Traoré SS; Simpore J; Bakri Y
J Public Health Afr; 2018 May; 9(1):663. PubMed ID: 30079159
[TBL] [Abstract][Full Text] [Related]
11. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
12. Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer.
Troudi W; Uhrhammer N; Romdhane KB; Sibille C; Amor MB; Khodjet El Khil H; Jalabert T; Mahfoudh W; Chouchane L; Ayed FB; Bignon YJ; Elgaaied AB
Cancer Biomark; 2008; 4(1):11-8. PubMed ID: 18334730
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses.
Russo A; Calò V; Agnese V; Bruno L; Corsale S; Augello C; Gargano G; Barbera F; Cascio S; Intrivici C; Rinaldi G; Gulotta G; Macaluso M; Surmacz E; Giordano A; Gebbia N; Bazan V
Breast Cancer Res Treat; 2007 Nov; 105(3):267-76. PubMed ID: 17221156
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
[TBL] [Abstract][Full Text] [Related]
15. A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques.
Bergman A; Flodin A; Engwall Y; Arkblad EL; Berg K; Einbeigi Z; Martinsson T; Wahlström J; Karlsson P; Nordling M
Fam Cancer; 2005; 4(2):89-96. PubMed ID: 15951958
[TBL] [Abstract][Full Text] [Related]
16. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Hillemanns P; Dörk T
Clin Genet; 2010 Oct; 78(4):364-72. PubMed ID: 20569256
[TBL] [Abstract][Full Text] [Related]
17. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis.
Bu R; Siraj AK; Al-Obaisi KA; Beg S; Al Hazmi M; Ajarim D; Tulbah A; Al-Dayel F; Al-Kuraya KS
Int J Cancer; 2016 Sep; 139(5):1091-7. PubMed ID: 27082205
[TBL] [Abstract][Full Text] [Related]
19. Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.
Riahi A; Kharrat M; Ghourabi ME; Khomsi F; Gamoudi A; Lariani I; May AE; Rahal K; Chaabouni-Bouhamed H
Clin Genet; 2015 Feb; 87(2):155-60. PubMed ID: 24372583
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
